Table 1.
Baseline characteristics of the population.
| Total Population n = 128 |
VA-ECMO First n = 97 |
IMPELLA® First n = 31 |
p | |
|---|---|---|---|---|
| Demographics and Medical History | ||||
| Age (years) | 53.8 ± 13.1 | 52 ± 12.4 | 59.4 ± 13.8 | 0.006 |
| Sex (male), n (%) | 93 (72.7%) | 70 (72.2%) | 23 (74.2%) | 0.825 |
| Body mass index (Kg/m2) | 27 ± 4.9 | 27 ± 5.1 | 26.7 ± 4.3 | 0.735 |
| Diabetes, n (%) | 25 (19.5%) | 18 (18.6%) | 7 (22.6%) | 0.660 |
| History of coronary artery disease, n (%) | 34 (26.6%) | 26 (26.8%) | 8 (25.8%) | 0.913 |
| History of stroke, n (%) | 4 (3.1%) | 2 (2.1%) | 2 (6.5%) | 0.260 |
| Peripheral artery disease, n (%) | 3 (2.3%) | 1 (1%) | 2 (6.5%) | 0.154 |
| Renal failure before admission, n (%) | 7 (5.5%) | 5 (5.2%) | 2 (6.5%) | 0.999 |
| Admission | ||||
| Acute myocardial infarction, n (%) | 72 (56.3%) | 51 (52.6%) | 21 (67.7%) | 0.138 |
| Left ventricular ejection fraction (LVEF,%) | 21.8 ± 15.5 | 19.1 ± 13.8 | 27.2 ± 17.6 | 0.017 |
| Creatinine (mg/L) | 18 ± 10.1 | 18.5 ± 10.3 | 16.5 ± 9.6 | 0.353 |
| Hemoglobin (g/dL) | 11.9 ± 2.6 | 11.3 ± 2.4 | 13.5 ± 2.6 | <0.001 |
| Lactate (mmol/L) | 5.82 ± 4.93 | 6.84 ± 5.33 | 3.03 ± 1.57 | <0.001 |
| ASAT (IU/L) | 460 ± 749 | 498.3 ± 835 | 348.8 ± 397.9 | 0.340 |
| ALAT (IU/L) | 269.5 ± 552.1 | 325.6 ± 627.5 | 104.8 ± 101.9 | 0.054 |
| PT (%) | 63.2 ± 31.2 | 61.7 ± 33.9 | 69 ± 17 | 0.322 |
| Bilirubin (mg/L) | 13.2 ± 14.5 | 14 ± 15.2 | 10.3 ± 11.7 | 0.289 |
| CRP-us (mg/L) | 68.7 ± 75.9 | 68.2 ± 71.7 | 70.3 ± 88.7 | 0.903 |
| Mechanical support | ||||
| VA-ECMO, n (%) | 107 (83.6%) | 97 (100%) | 10 (32.3%) | - |
| IMPELLA®, n (%) | 41 (32%) | 10 (10.3%) | 31 (100%) | - |
| IMPELLA-CP®, n (%) | 34 (26.6%) | 7 (7.2%) | 27 (87.1%) | - |
| VA-ECMO as first device, n (%) | 97 (75.8%) | 97 (100%) | - | - |
| IMPELLA® as first device, n (%) | 31 (24.2%) | - | 31 (100%) | - |
| Duration of MCS (days) | 8.6 ± 9.2 | 9.4 ± 10.1 | 6 ± 5 | 0.077 |
ASAT = aspartate aminotransferase; ALAT = alanine aminotransferase; PT = prothrombin time; CRP = C-reactive protein; VA-ECMO = veno-arterial membrane oxygenation; MCS = mechanical circulatory support.